↓ Skip to main content

Use of NSAIDs in treating patients with arthritis

Overview of attention for article published in Arthritis Research & Therapy, July 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
1 news outlet
twitter
10 X users
facebook
2 Facebook pages
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
416 Dimensions

Readers on

mendeley
751 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Use of NSAIDs in treating patients with arthritis
Published in
Arthritis Research & Therapy, July 2013
DOI 10.1186/ar4174
Pubmed ID
Authors

Leslie J Crofford

Abstract

Patients with rheumatic diseases, including rheumatoid arthritis and osteoarthritis, almost universally describe pain and stiffness as important contributors to reduced health-related quality of life. Of the treatment options available, NSAIDs are the most widely used agents for symptomatic treatment. NSAIDs are effective anti-inflammatory and analgesic drugs by virtue of their ability to inhibit biosynthesis of prostaglandins at the level of the cyclooxygenase enzyme. However, many of the adverse effects of NSAIDs are also related to inhibition of prostaglandin production, making their use problematic in some patient populations. For the clinician, understanding the biology of prostaglandin as it relates to gastrointestinal, renal, and cardiovascular physiology and the pharmacologic properties of specific NSAIDs is key to using these drugs safely. Of particular importance is the recognition of co-morbid conditions and concomitant drugs that may increase the risk of NSAIDs in particular patients. In patients with risk factors for NSAID toxicity, using the lowest dose of a drug with a short half-life only when it is needed is likely to be the safest treatment option. For those patients whose symptoms cannot be managed with intermittent treatment, using protective strategies is essential.

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 751 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Portugal 1 <1%
Malaysia 1 <1%
Australia 1 <1%
India 1 <1%
Argentina 1 <1%
Spain 1 <1%
Greece 1 <1%
United States 1 <1%
Unknown 743 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 123 16%
Student > Master 99 13%
Student > Ph. D. Student 79 11%
Student > Postgraduate 50 7%
Researcher 47 6%
Other 106 14%
Unknown 247 33%
Readers by discipline Count As %
Medicine and Dentistry 125 17%
Pharmacology, Toxicology and Pharmaceutical Science 116 15%
Biochemistry, Genetics and Molecular Biology 60 8%
Agricultural and Biological Sciences 57 8%
Chemistry 25 3%
Other 97 13%
Unknown 271 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2023.
All research outputs
#1,948,573
of 25,728,855 outputs
Outputs from Arthritis Research & Therapy
#302
of 3,411 outputs
Outputs of similar age
#16,185
of 210,408 outputs
Outputs of similar age from Arthritis Research & Therapy
#4
of 34 outputs
Altmetric has tracked 25,728,855 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,411 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,408 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.